USTR Is Investigating Whether China Broke the Phase One Trade Deal: What the October 27 Section 301 Action Means for Chemical Tariff Exclusions You're Counting On

On October 27, USTR published the initiation notice for a fresh Section 301 investigation into whether China has met the purchase and structural reform commitments of the January 2020 Economic and Trade Agreement, known in every trade lawyer’s shorthand as Phase One. Within 24 hours the Federal Register posted the 60-day comment window, and within 72 hours the first drafts of the talking points from Beijing’s embassy had hit the Washington circuit. For US chemical importers, most of the noise around this investigation has been political. The part that matters operationally is that 178 product categories currently enjoy Section 301 tariff exclusions, and a formal non-compliance finding gives USTR the legal cover to revoke or narrow those exclusions at essentially any time from the preliminary determination onwards.

If you’ve built your 2026 landed cost model around a specific exclusion line, whether it’s on epoxy resins, specialty solvents, pharmaceutical intermediates or rare earth compounds, you’ve just been put on a shot clock you didn’t know existed. The exclusion system was always discretionary. What the Phase One investigation does is create the political and legal justification to modify that discretion at speed, and the importers who don’t have a backup plan for exclusion revocation are the ones who’ll find out the hard way in Q1 or Q2 next year.

What the Investigation Actually Covers

Phase One was signed in January 2020 with three big commitments from China. First, purchase commitments of USD 200 billion in additional US exports over 2020 and 2021, broken out across manufactured goods, agricultural products, energy and services. Second, structural reforms on intellectual property protection, technology transfer, financial services market access and currency practices. Third, a bilateral evaluation and dispute resolution mechanism.

The purchase commitments were missed substantially. The Peterson Institute tracking through late 2021 had China at roughly 57% of the target, and the picture didn’t improve in 2022 or 2023 when the agreement technically continued in a rolling status. The structural reforms were partial at best, with intellectual property enforcement and technology transfer the two areas where US industry associations have consistently documented shortfalls. The bilateral mechanism was essentially frozen through the back half of 2022 onwards.

Against that backdrop, the October 27 initiation notice asks four specific questions that any chemical importer should read carefully. Whether China has complied with the purchase commitments. Whether China has complied with the structural reform commitments. Whether USTR should take action under Section 301(b) including modification of tariffs and exclusions. And whether the current exclusion list of 178 categories should remain in its current scope.

That fourth question is where you live. The exclusions that survived the October 2024 renewal cycle include specific lines on fluorinated polymers, phosphor compounds, certain rare earth oxides, pharmaceutical intermediates and textile-grade chemicals. A number of those exclusions cover single supplier relationships that, if the exclusion disappears, force an immediate 25% Section 301 tariff layer back onto the landed cost.

The Exclusions That Matter for Chemical Importers

The current exclusion list is structured by 10-digit HTSUS line. Some categories have broad exclusions that cover most of the chemistry in a particular HS chapter. Others have narrow exclusions tied to specific end-use certifications. The ones that chemical importers rely on most heavily, and that would hurt the most on revocation, fall into a handful of groupings.

The numbers look abstract until you plug them into a live contract. A mid-sized electronics-grade solvent importer running 500 tonnes per month at USD 3,500 per tonne CIF loses roughly USD 450,000 per month if the exclusion on 2904.90.50 evaporates. That’s USD 5.4 million annualised. For a distribution business running on 8% EBITDA, it’s a company-level event.

The timing exposure isn’t abstract either. USTR moved from investigation initiation to the first round of Section 301 tariffs in roughly 9 months in 2017 to 2018. The Phase One compliance investigation has a statutory 12-month maximum but nothing prevents faster action. A preliminary determination in Q1 2026 with a proposed exclusion modification list is completely plausible, and in that scenario the comment window on individual exclusion revocations might be 30 days, which is not enough time to pivot your sourcing.

The Exclusion Renewal Cycle You Need to Know

USTR’s exclusion process has worked through several renewal cycles, and each cycle has narrowed the list further. The October 2024 renewal extended the remaining exclusions through May 31, 2025, and the current batch has been rolling on shorter extensions since then. The practical pattern is clear. Each renewal cycle has seen 10% to 20% of prior exclusions dropped. A non-compliance finding accelerates that drop rate substantially.

If you’re relying on an exclusion today, the three questions you need answered by your trade counsel are as follows. First, what is the current expiration date of your specific exclusion? Second, is your exclusion in the category that overlaps with the sectors most likely flagged in a Phase One non-compliance finding (semiconductor inputs, pharmaceutical supply chain, critical minerals)? Third, what’s the renewal petition status for your exclusion, including who else has filed in support and whether anyone has filed in opposition?

The third question is the one most importers miss. USTR exclusion proceedings are public, and opposition filings from US domestic producers are available in the docket. If your exclusion has a strong US-side opposition filing, the probability of revocation is materially higher, and you can see this in the docket before USTR moves. Your trade counsel can pull the filings in a day.

Reciprocal Tariff Exclusion Interaction

The October 27 investigation also overlaps messily with the reciprocal tariff exclusion regime introduced in September. Some products enjoy both a Section 301 exclusion and a reciprocal tariff exclusion, and the two are independent. Losing one does not automatically affect the other, but the political dynamic is that a Phase One non-compliance finding gives USTR a public rationale to tighten both tracks in parallel.

The correlated risk is what makes scenario planning hard. If Section 301 exclusions get revoked and reciprocal exclusions also tighten and a Section 232 proclamation lands on your specific chemistry, your effective duty rate can move from 25% to 75% inside a single quarter. I’ve been doing this long enough to say that compound tariff shifts of that magnitude are rare, but not that rare, and 2026 is setting up to be one of those years.

The Actions You Take in the Next 60 Days

The comment window on the Phase One investigation is open through late December. The preliminary determination is likely in Q1 2026. The sequence that keeps you out of trouble is structured around that calendar.

First, identify every HTSUS line in your import mix that currently benefits from a Section 301 exclusion. Your broker can pull this from the last 12 months of 7501 entry summaries. The output is a clean list with line, annual volume, current CIF value and the duty delta between exclusion and revocation. That’s your exposure schedule.

Second, file a comment in the investigation docket. The comment period is not procedural theatre. USTR has historically weighted comments from importers who demonstrate specific supply chain dependency and lack of US domestic alternative. A well-written comment with specific volume data, alternative supplier analysis and landed cost implications can meaningfully shift the treatment of your specific exclusion in the preliminary determination.

Third, pre-qualify alternative suppliers for every exclusion-dependent line. Korea, Japan, Taiwan, India and Southeast Asia are the primary alternatives for most of the specialty chemistries that currently enjoy exclusions. The qualification timeline for a new chemical supplier is typically 3 to 6 months including sample shipments, QC validation and first production run. If you start in November, you have a supplier qualified by February. If you wait until the preliminary determination lands, you’re behind the curve.

Third-and-a-half, build a binding ruling portfolio for every product where classification is ambiguous. A CROSS ruling in hand is the single cleanest defence against a future CBP reclassification that retroactively strips an exclusion benefit. The cost is zero. The turnaround is 60 to 120 days. There is no reason not to file.

Fourth, rebuild your customer contracts to allow pricing adjustments on exclusion revocation. The Q1 2026 downside scenario for most chemical importers is that a specific exclusion disappears on 30 days notice, the landed cost rises by 25% to 30%, and your existing fixed-price customer contracts don’t reset until the next cycle. The gap between those two events is where margin goes to die. A specific Tariff Exclusion Adjustment clause in your customer contracts, permitting pass-through on documented USTR action, is the insurance that actually pays out.

Fifth, and this is the strategic play, build the case for exclusion continuation proactively. USTR renews exclusions based on petitions from US importers and their trade associations. If your exclusion is in a category where US production has expanded or where Chinese supply has diversified, your renewal case is weaker. If your case is that there is no US domestic alternative, that Chinese supply is irreplaceable for quality or volume reasons, and that revocation would damage downstream US industry, that case needs to be filed in writing before December and supported by specific numbers.

The Phase One investigation is not a political stunt. It’s the procedural setup for USTR’s next round of exclusion revocations, and the 178 categories on the current list are all in play. The importers who treat this as a 90-day sprint to audit exposure, file comments, qualify alternative suppliers and rewrite customer contracts will be the ones still quoting competitively in Q2 2026. The ones who wait for clarity will get exactly the clarity they asked for, in the form of an exclusion revocation notice with a 30-day effective date.

If you want Sourzi to run the exclusion exposure audit, draft the investigation comment filings and build the alternative supplier pipeline for your top 15 exclusion-dependent lines, send us your 12-month import history this week. We’ll have the exposure schedule back inside 10 working days, draft comment filings inside 21 days and a full alternative sourcing plan inside 45 days. After that, the preliminary determination window is closed and the options get narrower.